Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Avoid Traveling|I avoid traveling a response indicating that there was a disruption in a patient's therapy because their travel was restricted due to covid-19
The information collection burden associated with this measure is currently approved under OMB control number 0920-1317
The most commonly cited starting protocol in the medical literature and clinical practice involves 250 micrograms administered once daily for acute injury, stepping up to 500 micrograms daily if response is insufficient after one to two weeks
5mg research vial Stable lyophilized compound Research-grade formulation Laboratory research only Independently verified by Freedom Diagnostics via HPLC and mass spec
Most patients do not need additional numbing, or anesthetic
Bioactive Materials
US$ 26.89
US$ 26.69
US$ 21.59
US$ 28.79
